×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Marinus ...
fox5sandiego.com
SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and...
13 hours ago
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Marinus Pharmaceuticals, Inc ...
Business Wire
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities...
22 hours ago
MRNS INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to ...
GlobeNewswire
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action...
15 hours ago
IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Marinus ...
FOX40
LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is...
4 days ago
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Yahoo Finance
RADNOR, Pa., May 08, 2024--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative...
1 month ago
Marinus' Xtalmy comes up short in trial, shares plummet by 78%
Fierce Pharma
Marinus Pharmaceuticals' attempt to expand the use of its seizure medicine in a new formulation has hit a pothole. As a result, the company...
1 month ago
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 ...
Business Wire
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat...
1 month ago
Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program
Yahoo Finance
RADNOR, Pa., May 17, 2024--Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative...
3 weeks ago
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript March 5, 2024
Yahoo Finance
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript March 5, 2024 Marinus Pharmaceuticals, Inc. misses on earnings...
2 months ago